These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

568 related items for PubMed ID: 16103102

  • 1. FTY720 induces apoptosis in multiple myeloma cells and overcomes drug resistance.
    Yasui H, Hideshima T, Raje N, Roccaro AM, Shiraishi N, Kumar S, Hamasaki M, Ishitsuka K, Tai YT, Podar K, Catley L, Mitsiades CS, Richardson PG, Albert R, Brinkmann V, Chauhan D, Anderson KC.
    Cancer Res; 2005 Aug 15; 65(16):7478-84. PubMed ID: 16103102
    [Abstract] [Full Text] [Related]

  • 2. Antitumor activity of lysophosphatidic acid acyltransferase-beta inhibitors, a novel class of agents, in multiple myeloma.
    Hideshima T, Chauhan D, Hayashi T, Podar K, Akiyama M, Mitsiades C, MItsiades N, Gong B, Bonham L, de Vries P, Munshi N, Richardson PG, Singer JW, Anderson KC.
    Cancer Res; 2003 Dec 01; 63(23):8428-36. PubMed ID: 14679006
    [Abstract] [Full Text] [Related]

  • 3. MLN120B, a novel IkappaB kinase beta inhibitor, blocks multiple myeloma cell growth in vitro and in vivo.
    Hideshima T, Neri P, Tassone P, Yasui H, Ishitsuka K, Raje N, Chauhan D, Podar K, Mitsiades C, Dang L, Munshi N, Richardson P, Schenkein D, Anderson KC.
    Clin Cancer Res; 2006 Oct 01; 12(19):5887-94. PubMed ID: 17020997
    [Abstract] [Full Text] [Related]

  • 4. FTY720 induced Bcl-associated and Fas-independent apoptosis in human renal cancer cells in vitro and significantly reduced in vivo tumor growth in mouse xenograft.
    Ubai T, Azuma H, Kotake Y, Inamoto T, Takahara K, Ito Y, Kiyama S, Sakamoto T, Horie S, Muto S, Takahara S, Otsuki Y, Katsuoka Y.
    Anticancer Res; 2007 Oct 01; 27(1A):75-88. PubMed ID: 17352219
    [Abstract] [Full Text] [Related]

  • 5. Synergistic induction of oxidative injury and apoptosis in human multiple myeloma cells by the proteasome inhibitor bortezomib and histone deacetylase inhibitors.
    Pei XY, Dai Y, Grant S.
    Clin Cancer Res; 2004 Jun 01; 10(11):3839-52. PubMed ID: 15173093
    [Abstract] [Full Text] [Related]

  • 6. Selective cancer cell apoptosis induced by FTY720; evidence for a Bcl-dependent pathway and impairment in ERK activity.
    Azuma H, Horie S, Muto S, Otsuki Y, Matsumoto K, Morimoto J, Gotoh R, Okuyama A, Suzuki S, Katsuoka Y, Takahara S.
    Anticancer Res; 2003 Jun 01; 23(4):3183-93. PubMed ID: 12926052
    [Abstract] [Full Text] [Related]

  • 7. Sulindac-derived reactive oxygen species induce apoptosis of human multiple myeloma cells via p38 mitogen activated protein kinase-induced mitochondrial dysfunction.
    Seo SK, Lee HC, Woo SH, Jin HO, Yoo DH, Lee SJ, An S, Choe TB, Park MJ, Hong SI, Park IC, Rhee CH.
    Apoptosis; 2007 Jan 01; 12(1):195-209. PubMed ID: 17136320
    [Abstract] [Full Text] [Related]

  • 8. Novel inosine monophosphate dehydrogenase inhibitor VX-944 induces apoptosis in multiple myeloma cells primarily via caspase-independent AIF/Endo G pathway.
    Ishitsuka K, Hideshima T, Hamasaki M, Raje N, Kumar S, Podar K, Le Gouill S, Shiraishi N, Yasui H, Roccaro AM, Tai YZ, Chauhan D, Fram R, Tamura K, Jain J, Anderson KC.
    Oncogene; 2005 Sep 01; 24(38):5888-96. PubMed ID: 15940263
    [Abstract] [Full Text] [Related]

  • 9. Induction of apoptosis in human bladder cancer cells in vitro and in vivo caused by FTY720 treatment.
    Azuma H, Takahara S, Horie S, Muto S, Otsuki Y, Katsuoka Y.
    J Urol; 2003 Jun 01; 169(6):2372-7. PubMed ID: 12771800
    [Abstract] [Full Text] [Related]

  • 10. A novel Bcl-2/Bcl-X(L)/Bcl-w inhibitor ABT-737 as therapy in multiple myeloma.
    Chauhan D, Velankar M, Brahmandam M, Hideshima T, Podar K, Richardson P, Schlossman R, Ghobrial I, Raje N, Munshi N, Anderson KC.
    Oncogene; 2007 Apr 05; 26(16):2374-80. PubMed ID: 17016430
    [Abstract] [Full Text] [Related]

  • 11. Green tea component, catechin, induces apoptosis of human malignant B cells via production of reactive oxygen species.
    Nakazato T, Ito K, Ikeda Y, Kizaki M.
    Clin Cancer Res; 2005 Aug 15; 11(16):6040-9. PubMed ID: 16115949
    [Abstract] [Full Text] [Related]

  • 12. Antimyeloma effects of a sesquiterpene lactone parthenolide.
    Suvannasankha A, Crean CD, Shanmugam R, Farag SS, Abonour R, Boswell HS, Nakshatri H.
    Clin Cancer Res; 2008 Mar 15; 14(6):1814-22. PubMed ID: 18347184
    [Abstract] [Full Text] [Related]

  • 13. Triptolide overcomes dexamethasone resistance and enhanced PS-341-induced apoptosis via PI3k/Akt/NF-kappaB pathways in human multiple myeloma cells.
    Yang M, Huang J, Pan HZ, Jin J.
    Int J Mol Med; 2008 Oct 15; 22(4):489-96. PubMed ID: 18813856
    [Abstract] [Full Text] [Related]

  • 14. Antimyeloma activity of the orally bioavailable dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235.
    McMillin DW, Ooi M, Delmore J, Negri J, Hayden P, Mitsiades N, Jakubikova J, Maira SM, Garcia-Echeverria C, Schlossman R, Munshi NC, Richardson PG, Anderson KC, Mitsiades CS.
    Cancer Res; 2009 Jul 15; 69(14):5835-42. PubMed ID: 19584292
    [Abstract] [Full Text] [Related]

  • 15. OSU-03012, a novel celecoxib derivative, is cytotoxic to myeloma cells and acts through multiple mechanisms.
    Zhang S, Suvannasankha A, Crean CD, White VL, Johnson A, Chen CS, Farag SS.
    Clin Cancer Res; 2007 Aug 15; 13(16):4750-8. PubMed ID: 17699852
    [Abstract] [Full Text] [Related]

  • 16. Novel etodolac analog SDX-308 (CEP-18082) induces cytotoxicity in multiple myeloma cells associated with inhibition of beta-catenin/TCF pathway.
    Yasui H, Hideshima T, Ikeda H, Ocio EM, Kiziltepe T, Vallet S, Okawa Y, Neri P, Sukhdeo K, Podar K, Chauhan D, Richardson PG, Raje N, Carrasco DR, Anderson KC.
    Leukemia; 2007 Mar 15; 21(3):535-40. PubMed ID: 17268521
    [Abstract] [Full Text] [Related]

  • 17. Canonical nuclear factor kappaB pathway inhibition blocks myeloma cell growth and induces apoptosis in strong synergy with TRAIL.
    Romagnoli M, Desplanques G, Maïga S, Legouill S, Dreano M, Bataille R, Barillé-Nion S.
    Clin Cancer Res; 2007 Oct 15; 13(20):6010-8. PubMed ID: 17947462
    [Abstract] [Full Text] [Related]

  • 18. Flavokawain A, a novel chalcone from kava extract, induces apoptosis in bladder cancer cells by involvement of Bax protein-dependent and mitochondria-dependent apoptotic pathway and suppresses tumor growth in mice.
    Zi X, Simoneau AR.
    Cancer Res; 2005 Apr 15; 65(8):3479-86. PubMed ID: 15833884
    [Abstract] [Full Text] [Related]

  • 19. Involvement of Bcl-2 family members, phosphatidylinositol 3'-kinase/AKT and mitochondrial p53 in curcumin (diferulolylmethane)-induced apoptosis in prostate cancer.
    Shankar S, Srivastava RK.
    Int J Oncol; 2007 Apr 15; 30(4):905-18. PubMed ID: 17332930
    [Abstract] [Full Text] [Related]

  • 20. PC cell-derived growth factor confers resistance to dexamethasone and promotes tumorigenesis in human multiple myeloma.
    Wang W, Hayashi J, Serrero G.
    Clin Cancer Res; 2006 Jan 01; 12(1):49-56. PubMed ID: 16397023
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.